Sponsor
Zhongda Hospital
Clinical research sponsor
Clinical trials
26 shownTherapeutic Effect of Electroacupuncture at Zusanli (ST-36) on Diabetic Foot WoundsNCT07482137 · lead sponsor · 2025-07-15
RECRUITINGSafety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical StudyNCT07516704 · lead sponsor · 2026-04-01
NOT_YET_RECRUITINGPropranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical StudyNCT07311915 · lead sponsor · 2026-01-15
NOT_YET_RECRUITINGEffect of Roxadustat on Heart Failure Patients With Anaemia and Moderate-to-Severe Chronic Kidney DiseaseNCT07268807 · lead sponsor · 2025-12-01
NOT_YET_RECRUITINGCT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)NCT05704192 · lead sponsor · 2023-05-04
UNKNOWNImpact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)NCT05703750 · lead sponsor · 2023-05-04
UNKNOWNEndovascular Denervation (EDN) for the Treatment of Type 2 Diabetes MellitusNCT05673668 · lead sponsor · 2022-12-27
UNKNOWNEffects of Bashan on Glucose in Type 2 Diabetes Patients and Its Related MechanismsNCT05333822 · lead sponsor · 2021-03-01
COMPLETEDUsing Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic RetinopathyNCT04283162 · lead sponsor · 2020-03-01
UNKNOWNThe MILESTONE StudyNCT04086043 · lead sponsor · 2019-09-10
UNKNOWNRenal Denervation in Patients With Type 2 Diabetes MellitusNCT03418415 · lead sponsor · 2018-01-18
UNKNOWNDetermination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)NCT03024788 · lead sponsor · 2017-01-01
UNKNOWNEvaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)NCT03025919 · lead sponsor · 2017-01-01
UNKNOWNBariatric Arterial Embolization for Morbid ObesityNCT02786108 · lead sponsor · 2016-05-01
UNKNOWNEfficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes MellitusNCT02143765 · lead sponsor · 2014-05-01
COMPLETEDImpact of Peer Support on Diabetes in ChinaNCT02119572 · lead sponsor
UNKNOWNThe Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical StudyNCT06254690 · collaborator · 2024-01-01
RECRUITING3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal HypertensionNCT05475015 · collaborator · 2022-08-16
RECRUITINGPrevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of ChinaNCT05597709 · collaborator · 2022-07-01
RECRUITINGThe Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis AnalysisNCT06589154 · collaborator · 2024-10-10
COMPLETEDApplication of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate CancerNCT06509919 · collaborator · 2024-07-09
SUSPENDEDConducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate CancerNCT05940415 · collaborator · 2023-10-08
UNKNOWNClinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLCNCT03769805 · collaborator · 2019-06-15
UNKNOWNMR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)NCT03766880 · collaborator · 2018-12-04
COMPLETEDBenidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With HypertensionNCT02646397 · collaborator · 2016-02-01
UNKNOWNEfficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With MetforminNCT02280486 · collaborator · 2015-01-01
COMPLETEDSponsor roles
lead sponsor16
collaborator10
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.